25 January 2019 | Views
Pavan Choudary, Chairman and DG, MTaI
The government is looking at reducing the cost of healthcare in India and spread the benefits to the maximum people. However high customs duties, lack of incentives for R&D in medical device sector and high minimum alternate tax need to be addressed first. We feel the customs duties should be brought down to maximum of 2.5 percent, similar to many other countries. Also some leeway should be provided to medical devices manufacturers to increase the prices to maintain reasonable margins which are currently under threat due to high inflation and rupee depreciation.